One of the most exciting aspects of the cannabis industry is the limitless potential for growth. Investing in cannabis stocks now could yield tremendous financial gains in the future.
Because of marijuana’s current federal status, the majority of our recommendations are Canadian stocks. Trading stocks on thee Canadian market is legal for American citizens as long as you go through the proper channels to complete your purchase.
This Canadian producer is already one of the most successful up North, but they’re beginning to branch out globally. Their first key step is establishing a partnership with Southern Glazer’s, one of the largest wine and spirit distributors in the U.S.
Aurora Cannabis (ACB)
Although this stock isn’t profitable yet, it recently showed a tremendous surge in value. The Canadian cannabis company reported revenue of CA $132 million this quarter, up more than 52% from the previous quarter. With a surge in recreational and medical marijuana sales throughout Canada this year, expect this stock to continue climbing.
GW Pharmaceuticals (GWPH)
This company is responsible for Epidiolex, which is the only cannabis-derived drug currently approved by the FDA. The drug is used to treat seizures in certain rare forms of pediatric epilepsy and was also approved by the European Commission in September. With several other developments set to launch early next year, this stock is one to grab now before it gets too hot.
Weed MD (WDDMF)
The Canadian company reported more than $8 million in net revenue by the second half of this year and that number is only expected to continue to climb next year. With a sizable outdoor grow facility, they’re currently trading at a discount while still maintaining several catalysts for financial growth.
The Green Organic Dutchman (TGOD)
New to the cannabis scene, they made their way onto the Toronto Stock Exchange last year after quickly raising $99 million from their initial public offering. This stock is one to keep an eye on with how quickly the company is expanding. They’re currently building four massive grow facilities in Canada, Europe and the Caribbean that total 195,000 kilograms. They’re also to build a 40,000-square-foot research and development center for new products in the works.
Valens Groworks (VGWCF)
Stocks don’t get much cheaper than this. This extraction-services provider has an extremely low forward P/E ratio of 7. Valens finds itself in an ideal position because hemp and marijuana growers need cannabis and hemp biomass processed for distillates, concentrates and resins in order to develop derivatives such as edibles and vapes.
Supreme Cannabis Company (SPRWF)
This inexpensive, low-risk stock could pay off handsomely in the future. They’re focusing on quality over quantity, choosing to grow only 50,000 kilograms of premium and ultra-premium dried flower and derivatives. They’re moving into consumer-packaged goods and making a play for the retail market, which is expected to yield a significant profit by 2021.